German Study Gestational Diabetes (PREG)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Due to a changed lifestyle with less physical activity, unfavorable diets rich in fat and calories and obesity, the prevalence of diabetes mellitus is increasing worldwide. The diabetes epidemic is associated with significant personal and socio-economic consequences. Despite attempts to prevent the complications of diabetes, this disease is still the leading cause of blindness, chronic renal insufficiency and non-traumatic amputation. It is important to detect early on an increase in blood sugar and treat it accordingly to reduce costs and to minimize the personal suffering of those affected. As the number of patients with type 2 diabetes mellitus continues to rise, the number of young women with gestational diabetes mellitus (GDM) also increases. This is a disorder og glucose metabolism, which occurs for the first time in pregnancy. The causes for this are manifold. Among other causes, the increasing age of the mothers and weight gain during pregnancy are risk factors for gestational diabetes. Although it has been recommended that women with gestational diabetes should be re-examined after the birth of their child, many women have not. The study is a follow-up study to clarify whether insulin secretion disorder in women with and after GDM is a risk factor for the occurrence of type 2 diabetes mellitus.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ \- Signed and dated informed consent

⁃ Enrollment is possible during AND after gestation:

• Baseline visit (pregnancy): gestational week 24+0 till 31+6

• Postpartum visits: documented occurence of GDM in previous pregnancy

Locations
Other Locations
Germany
University Hospital Tuebingen
RECRUITING
Tübingen
Contact Information
Primary
Andreas Fritsche, MD
andreas.fritsche@med.uni-tuebingen.de
+49 7071 29
Backup
Louise Fritsche, PhD
louise.fritsche@med.uni-tuebingen.de
+49 7071 29
Time Frame
Start Date: 2012-05-23
Estimated Completion Date: 2028-05-01
Participants
Target number of participants: 800
Treatments
Women with GDM
Women without GDM
Sponsors
Leads: University Hospital Tuebingen
Collaborators: Universitätsklinikum Leipzig, IFB Adipositas Erkrankungen, Klinik für Diabetologie an der Medizinischen Klinik - Innenstadt, LMU München, Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, TU Dresden, Universitätsklinik Heidelberg, Abteilung Innere Medizin I, Schwerpunkt Endokrinologie und Stoffwechsel, Deutsches Diabeteszentrum (DDZ), Leibniz-Institut Düsseldorf

This content was sourced from clinicaltrials.gov